Next generation mitral valve, designed to facilitate patient lifetime management reports first uses in sternotomy, Minimally Invasive Cardiac Surgery (MICS) and robotic cases. Medtronic plc received U ...

SUNRISE-II feasibility trial marks the company’s entry into U.S. clinical development, advancing minimally invasive, anesthesia-free treatment approach ...

Edwards announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained ...

No longer a horizon technology, Artificial Intelligence in healthcare has reached a level of real-world performance that ...

The deal would fold the FDA-cleared Hotwire system, and the team behind Farapulse, into J&J’s expanding cardiac ablation business. According to a company press release, Johnson & Johnson has entered ...

Protect patient data with medical IoT security. Learn how AI, Zero Trust, and encryption can prevent cyber threats and secure ...

Designed to support a wide range of clinical workflows and surgical environments, Medtronic says, the Stealth AXiS system enables hospitals to adopt capabilities based on their needs, while ...

The TAVVE study will begin later this year with ten patients, whose 30-day safety results will be submitted to the FDA.

Companies developing or deploying AI systems now face increasing scrutiny around risk classification, transparency and ...

Validation documentation should define process parameters, monitoring strategies, and operating ranges that can support ...